248 related articles for article (PubMed ID: 16823975)
1. Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluid.
Burgess JA; Lescuyer P; Hainard A; Burkhard PR; Turck N; Michel P; Rossier JS; Reymond F; Hochstrasser DF; Sanchez JC
J Proteome Res; 2006 Jul; 5(7):1674-81. PubMed ID: 16823975
[TBL] [Abstract][Full Text] [Related]
2. Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags.
Dayon L; Hainard A; Licker V; Turck N; Kuhn K; Hochstrasser DF; Burkhard PR; Sanchez JC
Anal Chem; 2008 Apr; 80(8):2921-31. PubMed ID: 18312001
[TBL] [Abstract][Full Text] [Related]
3. Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF).
Maurer MH
Mass Spectrom Rev; 2010; 29(1):17-28. PubMed ID: 19116946
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E and other cerebrospinal fluid proteins differentiate ante mortem variant Creutzfeldt-Jakob disease from ante mortem sporadic Creutzfeldt-Jakob disease.
Choe LH; Green A; Knight RS; Thompson EJ; Lee KH
Electrophoresis; 2002 Jul; 23(14):2242-6. PubMed ID: 12210228
[TBL] [Abstract][Full Text] [Related]
5. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry.
Pan S; Zhu D; Quinn JF; Peskind ER; Montine TJ; Lin B; Goodlett DR; Taylor G; Eng J; Zhang J
Proteomics; 2007 Feb; 7(3):469-73. PubMed ID: 17211832
[TBL] [Abstract][Full Text] [Related]
6. CSF proteome: a protein repository for potential biomarker identification.
Romeo MJ; Espina V; Lowenthal M; Espina BH; Petricoin EF; Liotta LA
Expert Rev Proteomics; 2005 Jan; 2(1):57-70. PubMed ID: 15966853
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of protein depletion methods for the analysis of total-, phospho- and glycoproteins in lumbar cerebrospinal fluid.
Ogata Y; Charlesworth MC; Muddiman DC
J Proteome Res; 2005; 4(3):837-45. PubMed ID: 15952730
[TBL] [Abstract][Full Text] [Related]
8. Mining ventricular cerebrospinal fluid from patients with traumatic brain injury using hexapeptide ligand libraries to search for trauma biomarkers.
Sjödin MO; Bergquist J; Wetterhall M
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jul; 878(22):2003-12. PubMed ID: 20542479
[TBL] [Abstract][Full Text] [Related]
9. [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders].
Gabelle A; Roche S; Lehmann S
Rev Neurol (Paris); 2009 Mar; 165(3):213-22. PubMed ID: 18808768
[TBL] [Abstract][Full Text] [Related]
10. Application of an end-to-end biomarker discovery platform to identify target engagement markers in cerebrospinal fluid by high resolution differential mass spectrometry.
Paweletz CP; Wiener MC; Bondarenko AY; Yates NA; Song Q; Liaw A; Lee AY; Hunt BT; Henle ES; Meng F; Sleph HF; Holahan M; Sankaranarayanan S; Simon AJ; Settlage RE; Sachs JR; Shearman M; Sachs AB; Cook JJ; Hendrickson RC
J Proteome Res; 2010 Mar; 9(3):1392-401. PubMed ID: 20095649
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin D2 synthase and its post-translational modifications in neurological disorders.
Lescuyer P; Gandini A; Burkhard PR; Hochstrasser DF; Sanchez JC
Electrophoresis; 2005 Dec; 26(23):4563-70. PubMed ID: 16259013
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of the cerebrospinal fluid peptidome and proteome.
Zougman A; Pilch B; Podtelejnikov A; Kiehntopf M; Schnabel C; Kumar C; Mann M
J Proteome Res; 2008 Jan; 7(1):386-99. PubMed ID: 18052119
[TBL] [Abstract][Full Text] [Related]
13. Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease.
Choe LH; Dutt MJ; Relkin N; Lee KH
Electrophoresis; 2002 Jul; 23(14):2247-51. PubMed ID: 12210229
[TBL] [Abstract][Full Text] [Related]
14. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
[TBL] [Abstract][Full Text] [Related]
15. Development of affinity columns for the removal of high-abundance proteins in cerebrospinal fluid.
Ramström M; Zuberovic A; Grönwall C; Hanrieder J; Bergquist J; Hober S
Biotechnol Appl Biochem; 2009 Feb; 52(Pt 2):159-66. PubMed ID: 18412540
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.
Brechlin P; Jahn O; Steinacker P; Cepek L; Kratzin H; Lehnert S; Jesse S; Mollenhauer B; Kretzschmar HA; Wiltfang J; Otto M
Proteomics; 2008 Oct; 8(20):4357-66. PubMed ID: 18814332
[TBL] [Abstract][Full Text] [Related]
17. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.
Yin GN; Lee HW; Cho JY; Suk K
Brain Res; 2009 Apr; 1265():158-70. PubMed ID: 19368810
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive proteome map of bovine cerebrospinal fluid.
Brenn A; Karger A; Skiba M; Ziegler U; Groschup MH
Proteomics; 2009 Nov; 9(22):5199-205. PubMed ID: 19921684
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid proteome profile in multiple sclerosis.
Lehmensiek V; Süssmuth SD; Tauscher G; Brettschneider J; Felk S; Gillardon F; Tumani H
Mult Scler; 2007 Aug; 13(7):840-9. PubMed ID: 17881397
[TBL] [Abstract][Full Text] [Related]
20. CE MALDI-TOF/TOF MS for multiplexed quantification of proteins in human ventricular cerebrospinal fluid.
Zuberovic A; Wetterhall M; Hanrieder J; Bergquist J
Electrophoresis; 2009 May; 30(10):1836-43. PubMed ID: 19441030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
